Publications 1994

  1. A New Breed of Healthcare Professionals: A view on population health science Odyssey. 1, 46-51, 1994 MacLeod, S.M.
  2. An assessment of the methodologic quality and relevance of references in pharmaceutical advertisements in a Canadian medical journal. CMAJ 1994;151:47-54. Lexchin J, Holbrook AM.
  3. Argon green versus krypton red laser photocoagulation for extrafoveal choroidal neovascularization: One-year results in Ocular Histoplasmosis. Archives in Ophthalmology. 112:1166-1173. 1994 A. Cruess, A. Willan, M. Ballantyne
  4. Can Observational Studies Replace or Complement Experiment? J Rheumatol 1994;21(Supplement 41):57-61. van der Linden Sj, Goldsmith CH, Woodcock J, Nassonova V
  5. Can Specially Trained Physical Therapists Improve the Care of Patients with Rheumatoid Arthritis? A Randomized Health Care Trial. J Rheumatol 1994;21(1):70-79. Helewa A, Smythe HA, Goldsmith CH
  6. Corticosteroids in Patients with Rheumatoid Arthritis: Utility Measurements for Evaluating Risks and Benefits. Rev Rheum 1994;61(4):240-244. Ferraz MB, Quaresma MR, Goldsmith CH, Bennett KJ, Atra E
  7. Cost-effectiveness of enoxaparin versus warfarin prophylaxis against deep vein thrombosis after total hip replacement Canadian Medical Association Journal, 1994; 150:1083-1172 O'Brien BJ, Anderson D, Goeree R.
  8. Determining a minimal important change in a disease-specific quality of life questionnaire. Quality of Life Research. 3:43-48 1994 E.F. Juniper, G.H. Guyatt, A. Willan, L.E. Griffith.
  9. Determining a minimal important change in a disease-specific quality of life questionnaire. Journal of Clinical Epidemiology. 47:81-87. 1994 E.F. Juniper, G.H. Guyatt, A. Willan, L.E. Griffith.
  10. Development of a Self-Report Functional Status Index for Juvenile Rheumatoid Arthritis. J Rheumatol 1994;21(3):536-544. Wright FV, Law M, Crombie V, Goldsmith CH, Dent P
  11. Effect of increasing doses of beta-agonists on spirometric parameters, exercise capacity, and quality of life in patients with chronic airflow limitation. Thorax 49:479-484. 1994 R. Jaeschke, G. Guyatt, A. Willan, D. Cook, S. Harper, J. Morris, H. Ramsdale, R. Haddon, M. Newhouse.
  12. High dose rate versus low dose rate brachytherapy in carcinoma of the cervix: an economic analysis. British Journal of Radiology, 1994;67(803): 1113-1120. Jones G, Lukka H, O'Brien BJ.
  13. How to use the medical literature. IV. How to use an article about harm. JAMA 1994;271:1615-19. Levine M, Walter S, Lee H, Haines T, Holbrook AM, Moyer V, et al.
  14. How was your hospital stay? Patient's reports about their care in Canadian hospitals. Canadian Medical Association Journal, 1994;150:1813-1822. Charles C, Gauld M, Chambers L, O'Brien B, Haynes B, Labelle R.
  15. In search of power and significance: issues in the design and analysis of stochastic cost-effectiveness studies in health care Medical Care, 1994; 32:150-163 O'Brien BJ, Drummond MF, Labelle RJ, Willan A.
  16. Intermittent Cyclic Therapy with Etidronate in the Prevention of Corticosteroid-Induced Bone Loss. J Rheumatol 1994;21(10):1922-1926. Adachi JD, Cranney A, Goldsmith CH, Bensen WG, Bianchi F, Cividino A, Craig GL, Kaminska E, Sebaldt RJ, Papaioannou A, Boratto M, Gordon M, Steele M
  17. Low-dose cyclosporine for the treatment of crohn's disease. N Engl J Med 1994;330:1846-1851. Feagan BG, McDonald JWD, Rochon J et al., for the Canadian Crohn's Relapse Prevention Trial Investigators.
  18. Lymphoid Tissues Induce NGF-Dependent and NGF-Independent Neurite Outgrowth from Rat Superior Cervical Ganglia Explants in Culture. J Neurosci Res 1994;37(3):374-383. Kannan Y, Stead RH, Goldsmith CH, Bienenstock J
  19. Measurement of health-related quality-of-life in the economic evaluation of medicines Drug Information Journal, 1994; 28:45-53 O'Brien BJ.
  20. Occupation and the clinical characteristics of infertile couples. Canadian Journal of Public Health. 85:28-32 1994 J.A. Collins, E.A. Burrows, A. Willan.
  21. Performance of 27 MEDLINE systems tested by searches on clinical questions. Journal of the American Medical Informatics Association. 1:285-295 1994 B. Haynes, C. Walker, A. McKibbon, M. Johnson, A. Willan.
  22. Platelet Concentrates Stored for 5 Days in a Reduced Volume of Plasma Maintain Hemostatic Function and Viability. Transfusion 1994;34(1):44-47. Ali AM, Warkentin TE, Bardossy L, Goldsmith CH, Blajchman MA
  23. Power function arguments in support of an alternative approach for analyzing management trials. Controlled Clinical Trials. 15:211-219. 1994 A. Willan.
  24. Prevalence of migraine in Canada: a population-based survey. International Journal of Epidemiology, 1994;23(5):1020-1026. O'Brien BJ, Goeree R, Streiner D.
  25. Quality of life after myocardial infarction. Journal of Clinical Epidemiology. 47:1287-1296. 1994 T.K Hillers, G.H. Guyatt, N. Oldridge, J. Crowe, A. Willan, L.E. Griffith, D. Feeny.
  26. Reflections on a month in the life of the Ontario Drug Benefit Plan Canadian Medical Association Journal, 1994; 150:473-477 McIsaac W, Naylor CD, Anderson GM, O'Brien BJ.
  27. Relationship between symptoms and health-related quality-of-life in chronic lung disease Journal of General Internal Medicine, 1994; 9:46-48 Viramontes JL, O'Brien BJ.
  28. Risk factors for gastrointestinal bleeding in critically ill patients. New England Journal of Medicine. 330:377-381 1994 D.J. Cook, H.D. Fuller, G.H. Guyatt, J.C. Marshall, D. Leasa, R. Hall, T.L. Winton, F. Rutledge, T.J.R. Todd, P. Roy, J. Lacroix, L. Griffith, A. Willan.
  29. Saliva versus blood sampling for therapeutic drug monitoring in children: patients' and parental preferences and an economic analysis. Ther Drug Monit 1994;16:437-443. Gorodischer R, Burtin P, Hwang P, Levine M, Koren G.
  30. Sensitivity to Change of 3 Systemic Lupus Erythematosus Disease Activity Indices: International Validation. J Rheumatol 1994;21(8):1468-1471. Gladman DD, Goldsmith CH, Urowitz MB, Bacon P, Bombardier C, Isenberg D, Kalunian K, Liang MH, Maddison P, Nived O, Richter M, Snaith M, Symmons D, Zoma A
  31. Social Science Education as a Component of Medical Training. Soc.Sci.Med.39:1367-1373, 1994 MacLeod, S.M., McCullough, H.N.
  32. Statistical versus quantitative importance in the socio-economic evaluation of medicines Pharmacoeconomics, 1994;5:389-398. O'Brien BJ, Drummond MF.
  33. Survey of family physicians: what is their role in cancer patient care? Canadian Journal of Oncology. 4:285-290. 1994 R. Gilbert, A. Willan, S. Richardson, S. Sellick.
  34. The cost-effective use of drug therapy: The role for drug program sponsors, physicians and pharmaceutical manufacturers. Can J Clin Pharmacol 1994;1:53-54. Levine M
  35. The effect of biofeedback training on temperature control in reflex sympathetic dystrophy patients with sympathectomy. The Pain Clinic 1994;7(2):107-116. Weir R, Harvey D, McLoughlin D, Dermer SW, Goldsmith CH, Kinch J
  36. The Effects of Comprehensive Home Physiotherapy and Supervision on Patients with Ankylosing Spondylitis. An 8-month followup. J Rheumatol 1994;21(2):261-263. Kraag GR, Stokes BA, Groh J, Helewa A, Goldsmith CH
  37. Training Users in the Gross Motor Function Measure: Methodological and Practical Issues. Physical Ther 1994;74(7):630-636. Russell DJ, Rosenbaum PL, Lane M, Gowland C, Goldsmith CH, Boyce WF, Plews N
  38. Users' guides to the medical literature II. How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patient? JAMA 1994;271:59-63. Guyatt GH, Sackett DL, Cook DJ and the Evidence-Based Medicine Working Group.
  39. Users' guides to the medical literature IV. How to use an article about harm? JAMA 1994;271:1615-1619. Levine M, Walter S, Lee H, Holbrook A, Haines T, Moyer V, and the Evidenced-based Medicine Working Group.
  40. Users' guides to the medical literature. VI. How to use an overview. JAMA 1994;272:1367-1371. Oxman AD, Cook DJ, Guyatt G for the Evidence-Based Medicine Working Group.
  41. Warfarin and its drug/food interactions: A critical review of the literature. Annals Intern Med 1994;121:676-83. Wells PS, Holbrook AM, Crowther R, Hirsh J.
  42. Willingness-to-pay: a valid and reliable measure of health state preference? Medical Decision Making, 1994;14:289-297. O'Brien BJ, Viramontes JL.
Toronto Web Design by LinxSmart
Graphic Design by Electra